New clinical pathway - Acute Rheumatic Fever

You are here

Acute Rheumatic Fever (ARF) coupled with rheumatic heart disease (RHD) cause significant morbidity and premature mortality among Australian Aboriginal and Torres Strait Islander people. A new clinical pathway for ARF has been developed to assist clinicians recognise and manage suspected ARF in adult and paediatric patients presenting to the Emergency Department.

The Suspected Acute Rheumatic Fever Clinical Pathway embeds current evidence and best practice aligned with the 2020 Australian guideline for prevention, diagnosis and management of ARF and rheumatic heart disease (3rd ed). While not intended to replace clinical judgement the pathway has been developed to assist clinicians and be used in conjunction with other observation and diagnostic tools and pathways.

The pathway was written as a deliverable to support implementation of the Queensland Aboriginal and Torres Strait Islander, Rheumatic Heart Disease Action Plan 2018-2021 (Action Plan).

The development of this pathway was led by the Action Plan implementation workgroup, in consultation and collaboration with stakeholders including clinician representatives of metropolitan and regional Queensland, the Queensland RHD Register and Control Program, QEDSAP, Statewide Cardiac Clinical Network and Clinical Excellence Queensland. It has been endorsed by the Queensland Emergency Department Strategic Advisory Panel (QEDSAP) and Statewide Cardiac Clinical Network (SCCN) and is now available for statewide use.

For further information regarding the clinical pathway for suspected Acute Rheumatic Fever, please contact

Resource links for pathway